Brief: Janux Therapeutics Reports First Quarter 2022 Results And Business Highlights

Janux Therapeutics

10/05/2022 21:57

May 10 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
    * JANUX THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.32
    * JANUX THERAPEUTICS INC - QTRLY COLLABORATION REVENUE $1.6
MILLION VERSUS $380,000

Source text for Eikon:  ID:nBw7ynqLMa 
Further company coverage:  JANX.O 

 ((Reuters.Briefs@thomsonreuters.com;))